Plasma-soluble CD40 is related to cholesterol metabolism in patients with moderate hypercholesterolemia

References

• Erl W, Weber PC, Weber C. Monocytic cell adhesion to endothelial cells stimulated by oxidized low density lipoprotein is mediated by distinct endothelial ligands. Atherosclerosis 1998; 136: 297–303
   PubMed Web of Science ®Google Scholar
• Schonbeck U, Libby P. CD40 signaling and plaque instability. Circ Res 2001; 89: 1092–103
   PubMed Web of Science ®Google Scholar
• Lutgens E, Gorelik L, Daemen MJ, de Muinck ED, Grewal IS, Koteliansky VE, et al. Requirement for CD154 in the progression of atherosclerosis. Nat Med 1999; 5: 1313–6
   PubMed Web of Science ®Google Scholar
• Mach F, Schonbeck U, Sukhova GK, Bourcier T, Bonnefoy JY, Pober JS, et al. Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: Implications for CD40-CD40 ligand signaling in atherosclerosis. Proc Natl Acad Sci USA 1997; 94: 1931–6
   PubMed Web of Science ®Google Scholar
• Simonen PP, Gylling HK, Miettinen TA. Diabetes contributes to cholesterol metabolism regardless of obesity. Diabetes Care 2002; 25: 1511–5
   PubMed Web of Science ®Google Scholar
• Bjorkhem I, Diczfalusy U. Oxysterols: Friends, foes, or just fellow passengers?. Arterioscler Thromb Vasc Biol 2002; 22: 734–42
   PubMed Web of Science ®Google Scholar
• Paiva H, Thelen KM, Van Coster R, Smet J, De Paepe B, Mattila KM, et al. High-dose statins and skeletal muscle metabolism in humans: A randomized, controlled trial. Clin Pharmacol Ther 2005; 78: 60–8
   PubMed Web of Science ®Google Scholar
• Tone M, Tone Y, Fairchild PJ, Wykes M, Waldmann H. Regulation of CD40 function by its isoforms generated through alternative splicing. Proc Natl Acad Sci USA 2001; 98: 1751–6
   PubMed Web of Science ®Google Scholar
• Contin C, Pitard V, Itai T, Nagata S, Moreau JF, Dechanet-Merville J. Membrane-anchored CD40 is processed by the tumor necrosis factor-alpha-converting enzyme. Implications for CD40 signaling. J Biol Chem 2003; 278: 32801–9
   PubMed Web of Science ®Google Scholar
• De Paoli P, Cozzi M, Tedeschi R, Gloghini A, Cilia AM, van Kooten C, et al. High CD40 membrane expression in AIDS-related lymphoma B cell lines is associated with the CD45RA+, CD45RO+, CD95+ phenotype and high levels of its soluble form in culture supernatants. Cytometry 1997; 30: 33–8
   PubMedGoogle Scholar
• Garcia-Cruset S, Carpenter KL, Guardiola F, Stein BK, Mitchinson MJ. Oxysterol profiles of normal human arteries, fatty streaks and advanced lesions. Free Radic Res 2001; 35: 31–41
   PubMed Web of Science ®Google Scholar
• Babiker A, Andersson O, Lund E, Xiu RJ, Deeb S, Reshef A, et al. Elimination of cholesterol in macrophages and endothelial cells by the sterol 27-hydroxylase mechanism. Comparison with high density lipoprotein-mediated reverse cholesterol transport. J Biol Chem 1997; 272: 26253–61
   PubMed Web of Science ®Google Scholar
• Harik-Khan R, Holmes RP. Estimation of 26-hydroxycholesterol in serum by high-performance liquid chromatography and its measurement in patients with atherosclerosis. J Steroid Biochem 1990; 36: 351–5
   PubMedGoogle Scholar
• Lee WL, Lee WJ, Chen YT, Liu TJ, Liang KW, Ting CT, et al. The presence of metabolic syndrome is independently associated with elevated serum CD40 ligand and disease severity in patients with symptomatic coronary artery disease. Metabolism 2006; 55: 1029–34
   PubMed Web of Science ®Google Scholar
• Cipollone F, Mezzetti A, Porreca E, Di Febbo C, Nutini M, Fazia M, et al. Association between enhanced soluble CD40L and prothrombotic state in hypercholesterolemia: Effects of statin therapy. Circulation 2002; 106: 399–402
   PubMed Web of Science ®Google Scholar
• Wang TD, Chen WJ, Lin JW, Cheng CC, Chen MF, Lee YT. Efficacy of fenofibrate and simvastatin on endothelial function and inflammatory markers in patients with combined hyperlipidemia: Relations with baseline lipid profiles. Atherosclerosis 2003; 170: 315–23
   PubMed Web of Science ®Google Scholar
• Schonbeck U, Gerdes N, Varo N, Reynolds RS, Horton DB, Bavendiek U, et al. Oxidized low-density lipoprotein augments and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors limit CD40 and CD40L expression in human vascular cells. Circulation 2002; 106: 2888–93
   PubMed Web of Science ®Google Scholar
• Mulhaupt F, Matter CM, Kwak BR, Pelli G, Veillard NR, Burger F, et al. Statins (HMG-CoA reductase inhibitors) reduce CD40 expression in human vascular cells. Cardiovasc Res 2003; 59: 755–66
   PubMed Web of Science ®Google Scholar
• Garlichs CD, John S, Schmeisser A, Eskafi S, Stumpf C, Karl M, et al. Upregulation of CD40 and CD40 ligand (CD154) in patients with moderate hypercholesterolemia. Circulation 2001; 104: 2395–400
   PubMed Web of Science ®Google Scholar
• Li Y, Schwabe RF, DeVries-Seimon T, Yao PM, Gerbod-Giannone MC, Tall AR, et al. Free cholesterol-loaded macrophages are an abundant source of tumor necrosis factor-alpha and interleukin-6: Model of NF-kappaB- and map kinase-dependent inflammation in advanced atherosclerosis. J Biol Chem 2005; 280: 21763–72
   PubMed Web of Science ®Google Scholar
• Montero MT, Hernandez O, Suarez Y, Matilla J, Ferruelo AJ, Martinez-Botas J, et al. Hydroxymethylglutaryl-coenzyme A reductase inhibition stimulates caspase-1 activity and Th1-cytokine release in peripheral blood mononuclear cells. Atherosclerosis 2000; 153: 303–13
   PubMed Web of Science ®Google Scholar
• Takahashi HK, Mori S, Iwagaki H, Yoshino T, Tanaka N, Weitz-Schmidt G, et al. Differential effect of LFA703, pravastatin, and fluvastatin on production of IL-18 and expression of ICAM-1 and CD40 in human monocytes. J Leukoc Biol. 2004;77:400–7.
   PubMed Web of Science ®Google Scholar
• Seung HH, Koh KK, Quon MJ, Lee Y, Shin EK. The effects of simvastatin, losartan, and combined therapy on soluble CD40 ligand in hypercholesterolemic, hypertensive patients. Atherosclerosis. 2006. Article in press
   Web of Science ®Google Scholar